Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 01/14/14 → 01/22/17 |
Funding
- Celldex Therapeutics Incorporated: $26,516.29
A Phase II Study of Rindopepimut IGM-CSF in Patients with Relapsed EGFRvUI-Positive Glioblastoma (The ReACT Study)
- Kowalska, Agnieszka (PI)
- Gutman, Frederick (CoPI)
- Rosiello, Arthur (CoPI)
Project: Research